JRCT ID: jRCT2080220032
Registered date:06/09/2005
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Primary cervical cancer patients treated with radiotherapy |
Date of first enrollment | 06/09/2005 |
Target sample size | 240 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : Z-100 INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Injection |
Outcome(s)
Primary Outcome | Survival |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 79age old |
Gender | Female |
Include criteria | Inclusion Criteria: -Patients with FIGO Stage IIb - IVa. -Patients with squamous cell carcinoma histologically. Exclusion Criteria: -Patients with complication of cancers in addition to cervical cancer or patients who undergo the therapy. -Patients who contracted the cancers except for cervical cancer within 5 years. |
Exclude criteria |
Related Information
Primary Sponsor | ZERIA Pharmaceutical Co.,Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-050032 |
Contact
Public contact | |
Name | |
Address | kaihatu@zeria.co.jp |
Telephone | |
Affiliation | ZERIA Pharmaceutical Co.,Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |